MOKARI ATABAK (Chief Financial Officer) sold 72.4% of their position (40K shares) of CORCEPT THERAPEUTICS INC on the open market
Open‑market sale worth $2.80M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+40K
Price / share
$19.26
Trade value
$770.40K
% of position
Common Stock
Shares
−40K
Price / share
$70.00
Trade value
$2.80M
% of position
Common Stock
Shares
+634.00
Price / share
$70.44
Trade value
$44.66K
% of position
Common Stock
Shares
+634.00
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−395.00
Price / share
$70.44
Trade value
$27.82K
% of position
Net shares
+873.00
Net value
-$2.01M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | M · Option Exercise | +40K | $19.26 | $770.40K | 262.2% | 15.26K | 55.26K |
| Common Stock Direct | 6/1/2026 | S · Sale | −40K | $70.00 | $2.80M | 72.4% | 55.26K | 15.26K |
| Common Stock Direct | 6/1/2026 | A · Award | +634.00 | $70.44 | $44.66K | 4.2% | 15.26K | 15.89K |
| Common Stock Direct | 6/1/2026 | A · Award | +634.00 | — | — | 4.0% | 15.89K | 16.52K |
| Common Stock Direct | 6/2/2026 | F · Tax Withholding | −395.00 | $70.44 | $27.82K | 2.4% | 16.52K | 16.13K |
| Total | +873.00 | -$2.01M | ||||||
Stock option (right to buy)
Common Stock
40K shares
Shares
−40K
Strike price
19.26
Held after
60K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock40K shares | 6/1/2026 | M · Option Exercise | −40K | 19.26 | — | 60K |